Nickel Ferrite Nanoparticles Potentiate the Anticancer Effects of Doxorubicin in Human Lung A549 Cancer Cells
Journal of Applied Toxicology · 2026
DOI: 10.1002/jat.4955 ↗At a glance
Journal article in Journal of Applied Toxicology, 2026. Written by Seda Askin and 10 co-authors. Institution: Health Services Vocational School, Ataturk University, Erzurum, Turkey. Major MEDLINE topics: Doxorubicin, Nickel, Ferric Compounds, Lung Neoplasms. Cited 4 times so far (Crossref); 62 references. Funded by: Ataturk University.
Abstract (original language)
Nickel ferrite (NiFe₂O₄) nanoparticles, a class of Fe‐based magnetic nanoparticles (MNPs), have attracted increasing attention for cancer therapy because of their biocompatibility, magnetic responsiveness, and potential to enhance the efficacy of chemotherapeutic drugs. This study aimed to investigate the in vitro synergistic anticancer effect of NiFe₂O₄ nanoparticles in combination with doxorubicin (Dox) on human lung adenocarcinoma A549 cells. NiFe₂O₄ nanoparticles were synthesized and characterized by X‐ray diffraction (XRD), confirming spinel crystallinity; scanning electron microscopy (SEM), revealing nanorod morphology; and energy‐dispersive X‐ray spectroscopy (EDX), confirming elemental composition. X‐ray photoelectron microscope (XPS), Raman scattering, and also Brunauer–Emmett–Teller (BET) analysis were performed to understand the surface. Cytotoxicity was assessed by WST‐8 assay, and apoptosis induction was evaluated by mRNA expression analysis of CASP6, BAX, and BCL2 using RT‐qPCR. NiFe₂O₄ nanoparticles alone exhibited dose‐dependent cytotoxicity with an IC₅₀ of 69.59 μg/mL. When combined with subtoxic Dox (1.485 μM), a strong synergistic effect was observed, reducing the combination IC₅₀ to 15.39 μg/mL. Gene expression results indicated that the combination treatment significantly upregulated CASP6 and BAX, while downregulating BCL2, confirming enhanced apoptosis. NiFe₂O₄ nanoparticles potentiate the anticancer activity of doxorubicin in A549 cells at lower doses, suggesting a promising strategy to enhance efficacy while potentially reducing chemotherapeutic side effects.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Health Services Vocational School, Ataturk University, Erzurum, Turkey.
- Science Faculty, Department of Molecular Biology and Genetics, Ataturk University, Erzurum, Turkey.
- Medicine Faculty, Department of Radiation and Oncology, Ataturk University, Erzurum, Turkey.
- Health Services Vocational School, Ardahan University, Ardahan, Turkey.
- Science Faculty, Department of Chemistry, Ataturk University, Erzurum, Turkey.
ORCID profiles: Seda Askin, Hakan Askin
Funding
- Ataturk University
Cite
APA
Askin, S., Avci, B., Ozmen, H. K., Palabiyik, E., Oztanrikulu, B. D., Sevim, M., Uguz, H., Sulumer, A. N., Karadag, A. K., Yalcin, K., & Askin, H. (2026). Nickel Ferrite Nanoparticles Potentiate the Anticancer Effects of Doxorubicin in Human Lung A549 Cancer Cells. Journal of Applied Toxicology. https://doi.org/10.1002/jat.4955
Vancouver
Askin S, Avci B, Ozmen HK, Palabiyik E, Oztanrikulu BD, Sevim M, et al. Nickel Ferrite Nanoparticles Potentiate the Anticancer Effects of Doxorubicin in Human Lung A549 Cancer Cells. Journal of Applied Toxicology. 2026. doi:10.1002/jat.4955
BibTeX
@article{Askin2026,
author = {Askin, Seda and Avci, Bahri and Ozmen, Hilal Kiziltunc and Palabiyik, Esra and Oztanrikulu, Bercem Dilan and Sevim, Melike and Uguz, Handan and Sulumer, Ayse Nurseli and Karadag, Acelya Kardelen and Yalcin, Kadriye and Askin, Hakan},
title = {Nickel Ferrite Nanoparticles Potentiate the Anticancer Effects of Doxorubicin in Human Lung A549 Cancer Cells},
journal = {Journal of Applied Toxicology},
year = {2026},
doi = {10.1002/jat.4955}
}
EUVIMED